Price Alert

Cardio Diagnostics Inc. (CDIO)

NASDAQ: CDIO · Real-Time Price · USD

3.63

-0.39 (-9.77%)

At close: Aug 15, 2025, 3:49 PM

-9.77% (1D)

Bid	3.58
Market Cap	6.31M
Revenue (ttm)	19.9K
Net Income (ttm)	-5.85M
EPS (ttm)	-4.34
PE Ratio (ttm)	-0.84
Forward PE	-0.21
Analyst	Hold

Ask	3.74
Volume	32,079
Avg. Volume (20D)	52,280
Open	4.00
Previous Close	4.02
Day's Range	3.61 - 4.00
52-Week Range	3.22 - 53.10
Beta	2.91

About CDIO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CDIO

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CDIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

New

Cardio Diagnostics has released their quartely earnings on Aug 14, 2025:

Revenue of $7.47K misses estimates by $67.53K, with -5.02% YoY decline.

EPS of -0.97 exceeds estimates by 0.83, with 46.11% YoY growth.

Next Earnings Release

Cardio Diagnostics Inc. is scheduled to release its earnings on Nov 12, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 months ago

-47.09%

Cardio Diagnostics Holdings shares are trading low... Unlock content with Pro Subscription

News

3 weeks ago · businesswire.com

Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics CMS has issued preliminary gapfill payment rates of $350 for Epi+Gen CHD™ and $684.76 for PrecisionCHD™.

1 month ago · businesswire.com

Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced an agreement with AGEPHA Pharma.

2 months ago · businesswire.com

Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced that the Japan Patent Office has issued a patent for another set of biomarkers in the company's IP portfolio.

2 months ago · businesswire.com

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced it has regained compliance with Nasdaq minimum bid price.

2 months ago · businesswire.com

Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics has the continued expansion of its reach with a new cohort of healthcare practices across the United States.